nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—ADRBK1—peripheral nervous system—restless legs syndrome	0.0893	0.188	CbGeAlD
Isoprenaline—PIK3R2—nervous system—restless legs syndrome	0.039	0.0823	CbGeAlD
Isoprenaline—PIK3R2—central nervous system—restless legs syndrome	0.0376	0.0793	CbGeAlD
Isoprenaline—PIK3R2—brain—restless legs syndrome	0.0298	0.0629	CbGeAlD
Isoprenaline—MAPK1—brainstem—restless legs syndrome	0.0295	0.0621	CbGeAlD
Isoprenaline—PIK3R1—spinal cord—restless legs syndrome	0.0269	0.0566	CbGeAlD
Isoprenaline—PIK3R3—nervous system—restless legs syndrome	0.0265	0.0559	CbGeAlD
Isoprenaline—PIK3R3—central nervous system—restless legs syndrome	0.0255	0.0538	CbGeAlD
Isoprenaline—PIK3R3—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.0249	0.0474	CbGpPWpGaD
Isoprenaline—MAPK1—Trk receptor signaling mediated by the MAPK pathway—MAP2K5—restless legs syndrome	0.0226	0.0429	CbGpPWpGaD
Isoprenaline—PIK3R3—brain—restless legs syndrome	0.0203	0.0427	CbGeAlD
Isoprenaline—PIK3R2—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.0202	0.0385	CbGpPWpGaD
Isoprenaline—PIK3R2—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.0199	0.0378	CbGpPWpGaD
Isoprenaline—MAPK1—spinal cord—restless legs syndrome	0.0183	0.0386	CbGeAlD
Isoprenaline—PIK3R1—brain—restless legs syndrome	0.0173	0.0365	CbGeAlD
Isoprenaline—PIK3R2—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.0173	0.0329	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.0164	0.0312	CbGpPWpGaD
Isoprenaline—PIK3R1—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.0161	0.0306	CbGpPWpGaD
Isoprenaline—PIK3R1—EPHB forward signaling—TF—restless legs syndrome	0.0159	0.0302	CbGpPWpGaD
Isoprenaline—ADRBK1—nervous system—restless legs syndrome	0.0157	0.033	CbGeAlD
Isoprenaline—MAPK1—nervous system—restless legs syndrome	0.0154	0.0325	CbGeAlD
Isoprenaline—MAPK1—Cardiac Hypertrophic Response—MAP2K5—restless legs syndrome	0.0154	0.0292	CbGpPWpGaD
Isoprenaline—ADRBK1—central nervous system—restless legs syndrome	0.0151	0.0318	CbGeAlD
Isoprenaline—PIK3R3—Insulin Signaling—MAP2K5—restless legs syndrome	0.0149	0.0283	CbGpPWpGaD
Isoprenaline—MAPK1—central nervous system—restless legs syndrome	0.0149	0.0313	CbGeAlD
Isoprenaline—PIK3R1—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.0135	0.0256	CbGpPWpGaD
Isoprenaline—PIK3R2—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.0129	0.0245	CbGpPWpGaD
Isoprenaline—PIK3R3—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.0122	0.0231	CbGpPWpGaD
Isoprenaline—ADRBK1—brain—restless legs syndrome	0.012	0.0252	CbGeAlD
Isoprenaline—PIK3R2—Insulin Signaling—MAP2K5—restless legs syndrome	0.0119	0.0226	CbGpPWpGaD
Isoprenaline—MAPK1—brain—restless legs syndrome	0.0118	0.0249	CbGeAlD
Isoprenaline—PIK3R2—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.0117	0.0223	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways in Glioblastoma—MAP2K5—restless legs syndrome	0.0112	0.0212	CbGpPWpGaD
Isoprenaline—MAPK1—MicroRNAs in cardiomyocyte hypertrophy—MAP2K5—restless legs syndrome	0.0109	0.0208	CbGpPWpGaD
Isoprenaline—MAPK1—EPHB forward signaling—TF—restless legs syndrome	0.0108	0.0205	CbGpPWpGaD
Isoprenaline—PIK3R1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.0105	0.0199	CbGpPWpGaD
Isoprenaline—PIK3R2—Focal Adhesion—MAP2K5—restless legs syndrome	0.0103	0.0197	CbGpPWpGaD
Isoprenaline—PIK3R2—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00969	0.0184	CbGpPWpGaD
Isoprenaline—PIK3R1—Insulin Signaling—MAP2K5—restless legs syndrome	0.00961	0.0183	CbGpPWpGaD
Isoprenaline—ADRBK1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00955	0.0182	CbGpPWpGaD
Isoprenaline—PIK3R1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00952	0.0181	CbGpPWpGaD
Isoprenaline—MAPK1—Integrin-mediated Cell Adhesion—MAP2K5—restless legs syndrome	0.00952	0.0181	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by NGF—MAP2K5—restless legs syndrome	0.00935	0.0178	CbGpPWpGaD
Isoprenaline—MAPK1—ErbB1 downstream signaling—MAP2K5—restless legs syndrome	0.00915	0.0174	CbGpPWpGaD
Isoprenaline—PIK3R1—Focal Adhesion—MAP2K5—restless legs syndrome	0.00838	0.0159	CbGpPWpGaD
Isoprenaline—PIK3R1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00785	0.0149	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by NGF—MAP2K5—restless legs syndrome	0.00745	0.0142	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by NGF—MAP2K5—restless legs syndrome	0.00734	0.014	CbGpPWpGaD
Isoprenaline—MAPK1—BDNF signaling pathway—MAP2K5—restless legs syndrome	0.00711	0.0135	CbGpPWpGaD
Isoprenaline—ADRB1—nervous system—restless legs syndrome	0.00655	0.0138	CbGeAlD
Isoprenaline—MAPK1—Insulin Signaling—MAP2K5—restless legs syndrome	0.00653	0.0124	CbGpPWpGaD
Isoprenaline—MAPK1—EGF/EGFR Signaling Pathway—MAP2K5—restless legs syndrome	0.00647	0.0123	CbGpPWpGaD
Isoprenaline—ADRB1—central nervous system—restless legs syndrome	0.00631	0.0133	CbGeAlD
Isoprenaline—MAPK1—MAPK Signaling Pathway—MAP2K5—restless legs syndrome	0.00628	0.0119	CbGpPWpGaD
Isoprenaline—PIK3R3—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00614	0.0117	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by NGF—MAP2K5—restless legs syndrome	0.00604	0.0115	CbGpPWpGaD
Isoprenaline—MAPK1—Focal Adhesion—MAP2K5—restless legs syndrome	0.00569	0.0108	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—MAP2K5—restless legs syndrome	0.00534	0.0101	CbGpPWpGaD
Isoprenaline—ADRB1—brain—restless legs syndrome	0.00501	0.0106	CbGeAlD
Isoprenaline—ADRBK1—Opioid Signalling—POMC—restless legs syndrome	0.00495	0.00942	CbGpPWpGaD
Isoprenaline—PIK3R2—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00489	0.0093	CbGpPWpGaD
Isoprenaline—CYP1A1—nervous system—restless legs syndrome	0.00422	0.00891	CbGeAlD
Isoprenaline—MAPK1—Signaling by NGF—MAP2K5—restless legs syndrome	0.00411	0.00781	CbGpPWpGaD
Isoprenaline—CYP1A1—central nervous system—restless legs syndrome	0.00407	0.00858	CbGeAlD
Isoprenaline—PIK3R1—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00396	0.00754	CbGpPWpGaD
Isoprenaline—CYP1A1—brain—restless legs syndrome	0.00323	0.00681	CbGeAlD
Isoprenaline—PIK3R3—Hemostasis—TF—restless legs syndrome	0.00316	0.00601	CbGpPWpGaD
Isoprenaline—ADRB3—G alpha (s) signalling events—POMC—restless legs syndrome	0.00283	0.00538	CbGpPWpGaD
Isoprenaline—MAPK1—Opioid Signalling—POMC—restless legs syndrome	0.00277	0.00527	CbGpPWpGaD
Isoprenaline—MAPK1—Glucocorticoid receptor regulatory network—POMC—restless legs syndrome	0.00274	0.00522	CbGpPWpGaD
Isoprenaline—MAPK1—Platelet activation, signaling and aggregation—TF—restless legs syndrome	0.00269	0.00512	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TF—restless legs syndrome	0.00252	0.00479	CbGpPWpGaD
Isoprenaline—MAPK1—Corticotropin-releasing hormone—POMC—restless legs syndrome	0.0025	0.00476	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TF—restless legs syndrome	0.00204	0.00388	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MAP2K5—restless legs syndrome	0.00201	0.00382	CbGpPWpGaD
Isoprenaline—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—restless legs syndrome	0.00195	0.00371	CbGpPWpGaD
Isoprenaline—ADRB1—G alpha (s) signalling events—POMC—restless legs syndrome	0.00168	0.00319	CbGpPWpGaD
Isoprenaline—ADRB2—G alpha (s) signalling events—POMC—restless legs syndrome	0.00164	0.00312	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MAP2K5—restless legs syndrome	0.0016	0.00304	CbGpPWpGaD
Isoprenaline—CYP1A1—Phase 1 - Functionalization of compounds—POMC—restless legs syndrome	0.00158	0.00301	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MAP2K5—restless legs syndrome	0.00158	0.003	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TF—restless legs syndrome	0.00139	0.00264	CbGpPWpGaD
Isoprenaline—ADRB3—Class A/1 (Rhodopsin-like receptors)—POMC—restless legs syndrome	0.00135	0.00256	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.00133	0.00252	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAP2K5—restless legs syndrome	0.0013	0.00247	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAP2K5—restless legs syndrome	0.00127	0.00241	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.00106	0.00201	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR ligand binding—POMC—restless legs syndrome	0.00103	0.00195	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—POMC—restless legs syndrome	0.000921	0.00175	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAP2K5—restless legs syndrome	0.000882	0.00168	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.000857	0.00163	CbGpPWpGaD
Isoprenaline—CYP1A1—Biological oxidations—POMC—restless legs syndrome	0.000841	0.0016	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—POMC—restless legs syndrome	0.000836	0.00159	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—restless legs syndrome	0.000801	0.00152	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—restless legs syndrome	0.000783	0.00149	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAP2K5—restless legs syndrome	0.000751	0.00143	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAP2K5—restless legs syndrome	0.000735	0.0014	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—POMC—restless legs syndrome	0.000734	0.0014	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—POMC—restless legs syndrome	0.000723	0.00137	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—POMC—restless legs syndrome	0.000667	0.00127	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—POMC—restless legs syndrome	0.000657	0.00125	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—POMC—restless legs syndrome	0.00061	0.00116	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—POMC—restless legs syndrome	0.000596	0.00113	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—POMC—restless legs syndrome	0.000595	0.00113	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—POMC—restless legs syndrome	0.000591	0.00112	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—POMC—restless legs syndrome	0.00058	0.0011	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—POMC—restless legs syndrome	0.00054	0.00103	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—POMC—restless legs syndrome	0.000527	0.001	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—POMC—restless legs syndrome	0.000494	0.000939	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—POMC—restless legs syndrome	0.000471	0.000895	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—POMC—restless legs syndrome	0.000394	0.000749	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—POMC—restless legs syndrome	0.000388	0.000738	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—POMC—restless legs syndrome	0.000382	0.000725	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—POMC—restless legs syndrome	0.000367	0.000698	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—POMC—restless legs syndrome	0.000345	0.000655	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—POMC—restless legs syndrome	0.000337	0.000641	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—POMC—restless legs syndrome	0.000323	0.000614	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—POMC—restless legs syndrome	0.000319	0.000607	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—POMC—restless legs syndrome	0.000313	0.000595	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—POMC—restless legs syndrome	0.000311	0.000592	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—POMC—restless legs syndrome	0.000306	0.000582	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—POMC—restless legs syndrome	0.000217	0.000412	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—POMC—restless legs syndrome	0.000185	0.000351	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—POMC—restless legs syndrome	0.000181	0.000344	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—POMC—restless legs syndrome	0.000144	0.000274	CbGpPWpGaD
